Sinning Jan-Malte, Ibrahim Karim, Schröder Jörg, Sef Davorin, Burzotta Francesco
Department of Cardiology, St Vinzenz Hospital Cologne, Cologne, Germany.
Department of Cardiology, Technische Universität Dresden (Campus Chemnitz), Klinikum Chemnitz, Chemnitz, Germany.
Eur Heart J Suppl. 2022 Dec 8;24(Suppl J):J37-J42. doi: 10.1093/eurheartjsupp/suac064. eCollection 2022 Nov.
Despite the routine use of percutaneous mechanical circulatory support (pMCS) with the Impella heart pump, vascular and bleeding complications may occur during removal with or without pre-closure. To safely close the large-bore access (LBA), post-hoc selection of the appropriate treatment of vascular complications is critical to patient recovery and survival. Femoral artery access is typically utilized for LBA, and percutaneous axillary artery access is a common alternative, especially in the instance of severe peripheral artery disease. Optimization of patient outcomes and efficiency of pMCS can be achieved with adequate arterial access using state-of-the-art techniques. Impella removal techniques with or without pre-closure will be addressed as well as the management of large-bore femoral access complications. In addition, treatment strategies to manage patient deterioration during a protected high-risk percutaneous coronary intervention will be provided.
尽管使用Impella心脏泵进行经皮机械循环支持(pMCS)已成为常规操作,但在移除装置时,无论是否进行预闭合,都可能发生血管和出血并发症。为了安全闭合大口径通路(LBA),事后选择合适的血管并发症治疗方法对于患者的康复和生存至关重要。股动脉通路通常用于LBA,经皮腋动脉通路是一种常见的替代方法,特别是在严重外周动脉疾病的情况下。使用先进技术实现充分的动脉通路,可以优化患者预后和pMCS的效率。本文将探讨有或没有预闭合情况下的Impella移除技术以及大口径股动脉通路并发症的管理。此外,还将提供在受保护的高风险经皮冠状动脉介入治疗期间管理患者病情恶化的治疗策略。